The Possible Ameliorative Effect of Empagliflozin on Testicular Toxicity induced by Haloperidol in Adult male Albino Rats
Abstract
Abstract Background: Haloperidol ( HALO ), a first-generation antipsychotic drug, is utilized globally. It works by antagonizing brain dopamine D2 receptors. HALO may negatively impact several sexual function characteristics. Empagliflozin ( EMPA ) has recently been approved as a class of anti-hyperglycemic drug. EMPA can also alleviate oxidative stress and the release of pro-inflammatory cytokines often caused by hyperglycemia. Therefore, the primary aim of this research was to ascertain whether EMPA could mitigate HALO-induced testicular toxicity. Forty mature male rats from the albino strain were separated into four groups of ten rats. These groups include: Control group, EMPA-treated group, HALO-treated group, and EMPA+HALO treated group. Hormonal levels, inflammatory, and oxidative stress biomarkers were evaluated. Histopathological examination was performed for the testicular tissues. Immunohistochemical evaluation was undertaken to measure the expression of Sirt1 and Beclin1 and the results were compared. Results: Results of this study demonstrated that HALO induced significant reduction in Testosterone, Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH). In addition, to significant increase in levels of inflammatory markers, as well as significant reduction in antioxidant levels. Histological and immunohistochemical examination of testicular tissues from HALO-treated group of rats proved that HALO resulted into significant testicular damage. On the…
How strong is the evidence?
Evidence Hub reads this as a preprint, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.